Works by De Giorgi, Ugo
Results: 195
Neoadjuvant vs. Adjuvant Chemotherapy in Muscle Invasive Bladder Cancer (MIBC): Analysis From the RISC Database.
- Published in:
- Frontiers in Oncology, 2018, p. N.PAG, doi. 10.3389/fonc.2018.00463
- By:
- Publication type:
- Article
PARP inhibitors in testicular germ cell tumors: what we know and what we are looking for.
- Published in:
- Frontiers in Genetics, 2024, p. 1, doi. 10.3389/fgene.2024.1480417
- By:
- Publication type:
- Article
Combined Oral Fentanyl Citrate and Midazolam as Premedication for Bone Marrow Aspiration and Biopsy in Patients with Hematological Malignancies: A Randomized, Controlled and Patient-Blinded Clinical Trial.
- Published in:
- Journal of Clinical Medicine, 2020, v. 9, n. 2, p. 395, doi. 10.3390/jcm9020395
- By:
- Publication type:
- Article
A Novel AKT1 , ERBB2 , ESR1 , KRAS , PIK3CA , and TP53 NGS Assay: A Non-Invasive Tool to Monitor Resistance Mechanisms to Hormonal Therapy and CDK4/6 Inhibitors.
- Published in:
- Biomedicines, 2024, v. 12, n. 10, p. 2183, doi. 10.3390/biomedicines12102183
- By:
- Publication type:
- Article
Long-Term Response to Tyrosine Kinase Inhibitors for Metastatic Renal Cell Carcinoma.
- Published in:
- Biomedicines, 2022, v. 10, n. 10, p. N.PAG, doi. 10.3390/biomedicines10102444
- By:
- Publication type:
- Article
Immune-Checkpoint Inhibitors in Advanced Bladder Cancer: Seize the Day.
- Published in:
- Biomedicines, 2022, v. 10, n. 2, p. 411, doi. 10.3390/biomedicines10020411
- By:
- Publication type:
- Article
68 Ga-PSMA-11 PET/CT-Guided Stereotactic Body Radiation Therapy Retreatment in Prostate Cancer Patients with PSA Failure after Salvage Radiotherapy.
- Published in:
- Biomedicines, 2020, v. 8, n. 12, p. 536, doi. 10.3390/biomedicines8120536
- By:
- Publication type:
- Article
An Italian, multicenter, real-world, retrospective study of first-line pazopanib in unselected metastatic renal-cell carcinoma patients: the 'Pamerit' study.
- Published in:
- Japanese Journal of Clinical Oncology, 2021, v. 51, n. 3, p. 484, doi. 10.1093/jjco/hyaa193
- By:
- Publication type:
- Article
Targeted therapies for advanced bladder cancer: new strategies with FGFR inhibitors.
- Published in:
- Therapeutic Advances in Medical Oncology, 2019, v. 11, p. N.PAG, doi. 10.1177/1758835919890285
- By:
- Publication type:
- Article
Association between circulating tumor cells and peripheral blood monocytes in metastatic breast cancer.
- Published in:
- Therapeutic Advances in Medical Oncology, 2019, v. 11, p. 1, doi. 10.1177/1758835919866065
- By:
- Publication type:
- Article
Association between circulating tumor cells and peripheral blood monocytes in metastatic breast cancer.
- Published in:
- Therapeutic Advances in Medical Oncology, 2019, v. 11, p. N.PAG, doi. 10.1177/1758835919866065
- By:
- Publication type:
- Article
Mesenchymal stem cells expressing GD2 and CD271 correlate with breast cancer-initiating cells in bone marrow.
- Published in:
- Cancer Biology & Therapy, 2011, v. 11, n. 9, p. 812, doi. 10.4161/cbt.11.9.15178
- By:
- Publication type:
- Article
Combining liquid biopsy and functional imaging analysis in metastatic castration‐resistant prostate cancer helps predict treatment outcome.
- Published in:
- Molecular Oncology, 2022, v. 16, n. 2, p. 538, doi. 10.1002/1878-0261.13120
- By:
- Publication type:
- Article
Immunogenomic profiles associated with response to life-prolonging agents in prostate cancer.
- Published in:
- British Journal of Cancer, 2023, v. 129, n. 7, p. 1050, doi. 10.1038/s41416-023-02354-3
- By:
- Publication type:
- Article
Circulating androgen receptor gene amplification and resistance to <sup>177</sup>Lu-PSMA-617 in metastatic castration-resistant prostate cancer: results of a Phase 2 trial.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Plasma tumour DNA as an early indicator of treatment response in metastatic castration-resistant prostate cancer.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Systemic immune-inflammation index in germ-cell tumours.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Correlation of [<sup>68</sup>Ga]Ga-PSMA PET/CT response and PSA decline in first-line enzalutamide for metastatic castration-resistant prostate cancer patients.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2024, v. 52, n. 1, p. 326, doi. 10.1007/s00259-024-06887-4
- By:
- Publication type:
- Article
Dosimetry and safety of 177Lu PSMA-617 along with polyglutamate parotid gland protector: preliminary results in metastatic castration-resistant prostate cancer patients.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2020, v. 47, n. 13, p. 3008, doi. 10.1007/s00259-020-04856-1
- By:
- Publication type:
- Article
<sup>68</sup>Ga-PSMA PET/CT in patients with recurrent prostate cancer after radical treatment: prospective results in 314 patients.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2018, v. 45, n. 12, p. 2035, doi. 10.1007/s00259-018-4067-3
- By:
- Publication type:
- Article
Prognostic value of 18F-choline PET/CT metabolic parameters in patients with metastatic castration-resistant prostate cancer treated with abiraterone or enzalutamide.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2018, v. 45, n. 3, p. 348, doi. 10.1007/s00259-017-3866-2
- By:
- Publication type:
- Article
F-Fluorocholine PET/CT for early response assessment in patients with metastatic castration-resistant prostate cancer treated with enzalutamide.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2015, v. 42, n. 8, p. 1276, doi. 10.1007/s00259-015-3042-5
- By:
- Publication type:
- Article
Erratum to: F-Fluorocholine PET/CT for early response assessment in patients with metastatic castration-resistant prostate cancer treated with enzalutamide.
- Published in:
- 2015
- By:
- Publication type:
- Erratum
Activity of Platinum-Based Chemotherapy in Patients With Advanced Prostate Cancer With and Without DNA Repair Gene Aberrations.
- Published in:
- JAMA Network Open, 2020, v. 3, n. 10, p. e2021692, doi. 10.1001/jamanetworkopen.2020.21692
- By:
- Publication type:
- Article
Relationship between lymphocytopenia and circulating tumor cells as prognostic factors for overall survival in metastatic breast cancer.
- Published in:
- 2012
- By:
- Publication type:
- journal article
Effect of systemic therapies or best supportive care after disease progression to both nivolumab and cabozantinib in metastatic renal cell carcinoma: The Meet‐Uro 19BEYOND study.
- Published in:
- Cancer Medicine, 2022, v. 11, n. 16, p. 3084, doi. 10.1002/cam4.4681
- By:
- Publication type:
- Article
Venous thromboembolism in metastatic urothelial carcinoma or variant histologies: incidence, associative factors, and effect on survival.
- Published in:
- Cancer Medicine, 2017, v. 6, n. 1, p. 186, doi. 10.1002/cam4.986
- By:
- Publication type:
- Article
Instrumental activities of daily living in older patients with metastatic prostate cancer: results from the meet-URO network ADHERE prospective study.
- Published in:
- Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-53581-4
- By:
- Publication type:
- Article
Body Mass Index in Patients Treated with Cabozantinib for Advanced Renal Cell Carcinoma: A New Prognostic Factor?
- Published in:
- Diagnostics (2075-4418), 2021, v. 11, n. 1, p. 138, doi. 10.3390/diagnostics11010138
- By:
- Publication type:
- Article
Ki67 and PR in Patients Treated with CDK4/6 Inhibitors: A Real-World Experience.
- Published in:
- Diagnostics (2075-4418), 2020, v. 10, n. 8, p. 573, doi. 10.3390/diagnostics10080573
- By:
- Publication type:
- Article
Decrease of Pro-Angiogenic Monocytes Predicts Clinical Response to Anti-Angiogenic Treatment in Patients with Metastatic Renal Cell Carcinoma.
- Published in:
- Cells (2073-4409), 2022, v. 11, n. 1, p. 17, doi. 10.3390/cells11010017
- By:
- Publication type:
- Article
New Prognostic Biomarkers in Metastatic Castration-Resistant Prostate Cancer.
- Published in:
- Cells (2073-4409), 2021, v. 10, n. 1, p. 193, doi. 10.3390/cells10010193
- By:
- Publication type:
- Article
Safety and clinical outcomes of patients treated with abiraterone acetate after docetaxel: results of the Italian Named Patient Programme.
- Published in:
- BJU International, 2015, v. 115, n. 5, p. 764, doi. 10.1111/bju.12857
- By:
- Publication type:
- Article
Systemic Immune-Inflammation Index Predicts the Clinical Outcome in Patients with mCRPC Treated with Abiraterone.
- Published in:
- Frontiers in Pharmacology, 2016, v. 7, p. 1, doi. 10.3389/fphar.2016.00376
- By:
- Publication type:
- Article
Radiotherapy and High-Dose Interleukin-2: Clinical and Immunological Results of a Proof of Principle Study in Metastatic Melanoma and Renal Cell Carcinoma.
- Published in:
- Frontiers in Immunology, 2021, v. 12, p. 1, doi. 10.3389/fimmu.2021.778459
- By:
- Publication type:
- Article
Clinical Outcomes of Patients With Metastatic Urothelial Carcinoma After Progression to Immune Checkpoint Inhibitors: A Retrospective Analysis by the Meet-Uro Group (Meet-URO 1 Study).
- Published in:
- Clinical Medicine Insights: Oncology, 2021, p. 1, doi. 10.1177/11795549211021667
- By:
- Publication type:
- Article
Clinical Outcomes of Patients With Metastatic Urothelial Carcinoma After Progression to Immune Checkpoint Inhibitors: A Retrospective Analysis by the Meet-Uro Group (Meet-URO 1 Study).
- Published in:
- Clinical Medicine Insights: Oncology, 2021, v. 15, p. 1, doi. 10.1177/11795549211021667
- By:
- Publication type:
- Article
Cell-free DNA as a diagnostic marker for cancer: current insights.
- Published in:
- OncoTargets & Therapy, 2016, v. 9, p. 6549, doi. 10.2147/OTT.S100901
- By:
- Publication type:
- Article
Salvage high-dose chemotherapy in patients with germ cell tumors.
- Published in:
- Cancer (0008543X), 2002, v. 95, n. 2, p. 309, doi. 10.1002/cncr.10672
- By:
- Publication type:
- Article
Local treatment for oligoprogressive metastatic sites of breast cancer: efficacy, toxicities and future perspectives.
- Published in:
- Clinical & Experimental Metastasis, 2024, v. 41, n. 6, p. 863, doi. 10.1007/s10585-024-10312-3
- By:
- Publication type:
- Article
The prognostic significance of lactate dehydrogenase levels in seminoma patients with advanced disease: an analysis by the Global Germ Cell Tumor Collaborative Group (G3).
- Published in:
- World Journal of Urology, 2021, v. 39, n. 9, p. 3407, doi. 10.1007/s00345-021-03635-3
- By:
- Publication type:
- Article
Outcome of Patients with Renal Cell Carcinoma and Multiple Glandular Metastases Treated with Targeted Agents.
- Published in:
- Oncology, 2017, v. 92, n. 5, p. 269, doi. 10.1159/000455970
- By:
- Publication type:
- Article
Ovarian Sertoli-Leydig Cell Tumor, Endometrioid-Like Yolk Sac Tumor, and Y-Chromosomal Material.
- Published in:
- Oncology, 2003, v. 64, n. 4, p. 370, doi. 10.1159/000070295
- By:
- Publication type:
- Article
Impact of the time interval between primary or interval surgery and adjuvant chemotherapy in ovarian cancer patients.
- Published in:
- Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1221096
- By:
- Publication type:
- Article
Impact of the time interval between primary or interval surgery and adjuvant chemotherapy in ovarian cancer patients.
- Published in:
- Frontiers in Oncology, 2023, p. 01, doi. 10.3389/fonc.2023.1221096
- By:
- Publication type:
- Article
Locoregional treatment of de novo stage IV breast cancer in the era of modern oncology.
- Published in:
- Frontiers in Oncology, 2023, v. 13, p. 1, doi. 10.3389/fonc.2023.1083297
- By:
- Publication type:
- Article
Advanced low grade serous ovarian cancer: A retrospective analysis of surgical and chemotherapeutic management in two high volume oncological centers.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.970918
- By:
- Publication type:
- Article
The prognostic value of baseline and early variations of peripheral blood inflammatory ratios and their cellular components in patients with metastatic renal cell carcinoma treated with nivolumab: The Δ-Meet-URO analysis.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.955501
- By:
- Publication type:
- Article
Optimizing the use of lenvatinib in combination with pembrolizumab in patients with advanced endometrial carcinoma.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.979519
- By:
- Publication type:
- Article
Sodium levels and immunotherapy efficacy in mRCC patients with bone metastases: sub analysis of Meet-Uro 15 study.
- Published in:
- Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2024.1361010
- By:
- Publication type:
- Article